Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricard Cervera

Showing results (331-340 of 412) with videos related to

Pageof 42
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|January 27, 2023
Fluctuation of Anti-Domain 1 and Anti-β<sub>2</sub> -Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid AntibodiesCecilia B Chighizola, Francesca Pregnolato, Danieli Andrade, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 24, 2011
Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis TrialMaria S Stoenoiu, Selda Aydin, Maria Tektonidou, et al.
RMD Open|July 25, 2020
Development and preliminary validation of the Behçet's syndrome Overall Damage Index (BODI)Matteo Piga, Alberto Floris, Gerard Espinosa, et al.
Lupus Science & Medicine|July 23, 2025
Oral glucocorticoid patterns use in moderate to severe active SLE: insights from the Spanish SPOCS dataIñigo Rua-Figueroa, Ricard Cervera, Mercedes Freire-González, et al.
Lupus Science & Medicine|June 14, 2022
Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ('Registry')Zeynep Belce Erton, Ecem Sevim, Guilherme Ramires de Jesús, et al.
Medrxiv : the Preprint Server for Health Sciences|February 26, 2024
A genome-wide association study suggests new susceptibility loci for primary antiphospholipid syndromeDesiré Casares-Marfil, Manuel Martínez-Bueno, Maria Orietta Borghi, et al.
American Journal of Clinical and Experimental Immunology|July 26, 2013
Gastrointestinal-associated autoantibodies in different autoimmune diseasesDana Ben-Ami Shor, Hedi Orbach, Mona Boaz, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 8, 2024
A Genome-Wide Association Study Suggests New Susceptibility Loci for Primary Antiphospholipid SyndromeDesiré Casares-Marfil, Manuel Martínez-Bueno, Maria Orietta Borghi, et al.
Medicine|October 8, 2003
Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patientsRicard Cervera, Munther A Khamashta, Josep Font, et al.
Autoimmunity Reviews|April 1, 2024
Disease phenotypes in adult patients with suspected undifferentiated autoinflammatory diseases and PFAPA syndrome: Clinical and therapeutic implicationsVerónica Gómez-Caverzaschi, Jordi Yagüe, Gerard Espinosa, et al.
Pageof 42

Showing results (331-340 of 412) with videos related to

Sort By:
Pageof 42
Arthritis & Rheumatology (Hoboken, N.J.)|January 27, 2023
Fluctuation of Anti-Domain 1 and Anti-β<sub>2</sub> -Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid AntibodiesCecilia B Chighizola, Francesca Pregnolato, Danieli Andrade, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 24, 2011
Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis TrialMaria S Stoenoiu, Selda Aydin, Maria Tektonidou, et al.
RMD Open|July 25, 2020
Development and preliminary validation of the Behçet's syndrome Overall Damage Index (BODI)Matteo Piga, Alberto Floris, Gerard Espinosa, et al.
Lupus Science & Medicine|July 23, 2025
Oral glucocorticoid patterns use in moderate to severe active SLE: insights from the Spanish SPOCS dataIñigo Rua-Figueroa, Ricard Cervera, Mercedes Freire-González, et al.
Lupus Science & Medicine|June 14, 2022
Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ('Registry')Zeynep Belce Erton, Ecem Sevim, Guilherme Ramires de Jesús, et al.
Medrxiv : the Preprint Server for Health Sciences|February 26, 2024
A genome-wide association study suggests new susceptibility loci for primary antiphospholipid syndromeDesiré Casares-Marfil, Manuel Martínez-Bueno, Maria Orietta Borghi, et al.
American Journal of Clinical and Experimental Immunology|July 26, 2013
Gastrointestinal-associated autoantibodies in different autoimmune diseasesDana Ben-Ami Shor, Hedi Orbach, Mona Boaz, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 8, 2024
A Genome-Wide Association Study Suggests New Susceptibility Loci for Primary Antiphospholipid SyndromeDesiré Casares-Marfil, Manuel Martínez-Bueno, Maria Orietta Borghi, et al.
Medicine|October 8, 2003
Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patientsRicard Cervera, Munther A Khamashta, Josep Font, et al.
Autoimmunity Reviews|April 1, 2024
Disease phenotypes in adult patients with suspected undifferentiated autoinflammatory diseases and PFAPA syndrome: Clinical and therapeutic implicationsVerónica Gómez-Caverzaschi, Jordi Yagüe, Gerard Espinosa, et al.
Pageof 42